Related Experiment Video
Updated: Jun 10, 2026
07:25
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Antiviral therapy for chronic hepatitis B
Syed-Mohammed R Jafri1, Anna Suk-Fong Lok
1University of Michigan Health System, Ann Arbor, 48109, USA.
Clinics in Liver Disease
|July 20, 2010
Summary
Antiviral therapy for chronic hepatitis B aims to prevent liver cirrhosis and cancer. Approved treatments effectively suppress hepatitis B virus (HBV) replication, preventing disease progression.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Chronic hepatitis B poses a significant risk for developing cirrhosis and hepatocellular carcinoma.
- Effective management strategies are crucial to prevent long-term liver damage.
Purpose of the Study:
- To outline the goals and endpoints of antiviral therapy for chronic hepatitis B.
- To describe the factors influencing treatment decisions and available therapeutic options.
Main Methods:
- Treatment decisions are guided by hepatitis B virus (HBV) replication, liver disease stage, patient age, hepatitis B e antigen (HBeAg) status, and patient preference.
- Evaluation of treatment success includes viral suppression, alanine aminotransferase normalization, HBeAg loss, HBsAg loss, and histological improvement.
Main Results:
- Seven therapies, including interferon and nucleos(t)ide analogs, are approved for chronic hepatitis B treatment.
- These therapies demonstrate efficacy in suppressing HBV replication.
Conclusions:
- Antiviral therapies are effective in suppressing HBV replication.
- Approved treatments have been shown to prevent the progression of liver disease, including cirrhosis and hepatocellular carcinoma.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...